Bulletin
Investor Alert

press release

May 12, 2022, 7:05 a.m. EDT

Ionis to present at RBC Capital Markets Global Healthcare Conference

May 12, 2022 (PRNewswire via COMTEX) -- PR Newswire

CARLSBAD, Calif., May 12, 2022

CARLSBAD, Calif., May 12, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. /zigman2/quotes/201272020/composite IONS -3.17% today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 18, 2022.

A live webcast and additional information about this presentation can be accessed on the Investors & Media section of the Ionis website at www.ionispharma.com . A replay will be available on the Ionis website within 48 hours of each event.

About Ionis Pharmaceuticals, Inc. For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company.

To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

Cision
View original content to download multimedia: https://www.prnewswire.com/news-releases/ionis-to-present-at-rbc-capital-markets-global-healthcare-conference-301545318.html

SOURCE Ionis Pharmaceuticals, Inc.

COMTEX_407090268/2454/2022-05-12T07:05:11

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright (C) 2022 PR Newswire. All rights reserved

/zigman2/quotes/201272020/composite
US : U.S.: Nasdaq
$ 44.26
-1.45 -3.17%
Volume: 1.13M
Aug. 9, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$6.48 billion
Rev. per Employee
$1.27M
loading...

Comtex

Partner Center

Link to MarketWatch's Slice.